Pacific Biosciences of California Inc. buy Zacks Research
Start price
21.02.26
/
50%
€1.34
Target price
21.02.27
-
Performance (%)
-4.11%
Price
31.07.26
€1.21
Summary
This prediction is currently active. With a performance of -4.11%, the BUY prediction by Zacks_Research is trending in the wrong direction. This prediction currently runs until 21.02.27. The prediction end date can be changed by Zacks_Research at any time. Zacks_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pacific Biosciences of California Inc. | 1.171% | 1.171% |
| iShares Core DAX® | 2,59 % | 2,69 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % |
| iShares S&P 500 | -0,37 % | -0,83 % |
Comments by Zacks_Research for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California (NASDAQ:PACB) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Ratings data for PACB provided by MarketBeat